These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 28407691)

  • 1. TET2 and MEG3 promoter methylation is associated with acute myeloid leukemia in a Hainan population.
    Yao H; Duan M; Lin L; Wu C; Fu X; Wang H; Guo L; Chen W; Huang L; Liu D; Rao R; Wang S; Ding Y
    Oncotarget; 2017 Mar; 8(11):18337-18347. PubMed ID: 28407691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysfunction of the WT1-MEG3 signaling promotes AML leukemogenesis via p53-dependent and -independent pathways.
    Lyu Y; Lou J; Yang Y; Feng J; Hao Y; Huang S; Yin L; Xu J; Huang D; Ma B; Zou D; Wang Y; Zhang Y; Zhang B; Chen P; Yu K; Lam EW; Wang X; Liu Q; Yan J; Jin B
    Leukemia; 2017 Dec; 31(12):2543-2551. PubMed ID: 28400619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA-22 can regulate expression of the long non-coding RNA MEG3 in acute myeloid leukemia.
    Yao H; Sun P; Duan M; Lin L; Pan Y; Wu C; Fu X; Wang H; Guo L; Jin T; Ding Y
    Oncotarget; 2017 Sep; 8(39):65211-65217. PubMed ID: 29029424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The promoter of miR-663 is hypermethylated in Chinese pediatric acute myeloid leukemia (AML).
    Yan-Fang T; Jian N; Jun L; Na W; Pei-Fang X; Wen-Li Z; Dong W; Li P; Jian W; Xing F; Jian P
    BMC Med Genet; 2013 Jul; 14():74. PubMed ID: 23870168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased methylation upstream of the MEG3 promotor is observed in acute myeloid leukemia patients with better overall survival.
    Sellers ZP; Bolkun L; Kloczko J; Wojtaszewska ML; Lewandowski K; Moniuszko M; Ratajczak MZ; Schneider G
    Clin Epigenetics; 2019 Mar; 11(1):50. PubMed ID: 30876483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-suppressive MEG3 induces microRNA-493-5p expression to reduce arabinocytosine chemoresistance of acute myeloid leukemia cells by downregulating the METTL3/MYC axis.
    Wang A; Chen Y; Shi L; Li M; Li L; Wang S; Wang C
    J Transl Med; 2022 Jun; 20(1):288. PubMed ID: 35761379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA MEG3 contributes to drug resistance in acute myeloid leukemia by positively regulating ALG9 through sponging miR-155.
    Yu Y; Kou D; Liu B; Huang Y; Li S; Qi Y; Guo Y; Huang T; Qi X; Jia L
    Int J Lab Hematol; 2020 Aug; 42(4):464-472. PubMed ID: 32359033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2.
    Ko M; Huang Y; Jankowska AM; Pape UJ; Tahiliani M; Bandukwala HS; An J; Lamperti ED; Koh KP; Ganetzky R; Liu XS; Aravind L; Agarwal S; Maciejewski JP; Rao A
    Nature; 2010 Dec; 468(7325):839-43. PubMed ID: 21057493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA MAGI2-AS3 inhibits the self-renewal of leukaemic stem cells by promoting TET2-dependent DNA demethylation of the LRIG1 promoter in acute myeloid leukaemia.
    Chen L; Fan X; Zhu J; Chen X; Liu Y; Zhou H
    RNA Biol; 2020 Jun; 17(6):784-793. PubMed ID: 32174258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of TET2 and EZH2 gene functions in chromosome instability in acute myeloid leukemia.
    Wang J; He N; Wang R; Tian T; Han F; Zhong C; Zhang C; Hua M; Ji C; Ma D
    Sci Rep; 2020 Feb; 10(1):2706. PubMed ID: 32066746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA ANRIL promotes cell proliferation, migration and invasion during acute myeloid leukemia pathogenesis via negatively regulating miR-34a.
    Wang CH; Li QY; Nie L; Ma J; Yao CJ; Chen FP
    Int J Biochem Cell Biol; 2020 Feb; 119():105666. PubMed ID: 31830533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in TET2 and DNMT3A genes are associated with changes in global and gene-specific methylation in acute myeloid leukemia.
    Ponciano-Gómez A; Martínez-Tovar A; Vela-Ojeda J; Olarte-Carrillo I; Centeno-Cruz F; Garrido E
    Tumour Biol; 2017 Oct; 39(10):1010428317732181. PubMed ID: 28992762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TET2 expression is a potential prognostic and predictive biomarker in cytogenetically normal acute myeloid leukemia.
    Zhang TJ; Zhou JD; Yang DQ; Wang YX; Wen XM; Guo H; Yang L; Lian XY; Lin J; Qian J
    J Cell Physiol; 2018 Aug; 233(8):5838-5846. PubMed ID: 29219176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of Tet methylcytosine dioxygenase 2 (TET2) gene mutations in adult patients with acute myeloid leukemia: a meta-analysis.
    Liu WJ; Tan XH; Luo XP; Guo BP; Wei ZJ; Ke Q; He S; Cen H
    Leuk Lymphoma; 2014 Dec; 55(12):2691-8. PubMed ID: 24524305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Landscape of TET2 mutations in acute myeloid leukemia.
    Weissmann S; Alpermann T; Grossmann V; Kowarsch A; Nadarajah N; Eder C; Dicker F; Fasan A; Haferlach C; Haferlach T; Kern W; Schnittger S; Kohlmann A
    Leukemia; 2012 May; 26(5):934-42. PubMed ID: 22116554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrease of lncRNA MEG3 in Acute Myeloid Leukemia Affected the Expression of p53 and MDM2.
    Jia Y; He E; Peng J; Zhao M
    Clin Lab; 2023 Sep; 69(9):. PubMed ID: 37702691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of TET2 gene expression in 157 adult acute myeloid leukemia patients with normal cytogenetics].
    Zhu Z; Chen J; Yu M; Chen F; Chen Z; Lou J; Tong H; Huang J; Qian W; Meng H; Jin J
    Zhonghua Xue Ye Xue Za Zhi; 2014 Sep; 35(9):802-7. PubMed ID: 25246247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia.
    Tao YF; Fang F; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Li ZH; Wang NN; Xu LX; Du XJ; Sun LC; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
    BMC Cancer; 2015 Oct; 15():756. PubMed ID: 26490736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes.
    Benetatos L; Hatzimichael E; Dasoula A; Dranitsaris G; Tsiara S; Syrrou M; Georgiou I; Bourantas KL
    Leuk Res; 2010 Feb; 34(2):148-53. PubMed ID: 19595458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic impact of tet oncogene family member 2 mutations in patients with acute myeloid leukemia: a systematic-review and meta-analysis.
    Wang R; Gao X; Yu L
    BMC Cancer; 2019 Apr; 19(1):389. PubMed ID: 31023266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.